Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7332 p55
15 January 2005

This article
Reprint   Photocopy

PDF 110K, Acrobat Reader

Letters

· Fellowship of the Society (3)
· Overseas pharmacists (10)
· The Society (5)
· Retention fee (4)
· CPD (4)
· PECs
· Drug donations
· Dispensing errors
· Dispensing
· Morphine sulphate
· Near patient testing
· Slimming clubs
· New contract
· The Journal


Letters to the Editor

Near patient testing

Sharing experiences

From Dr B. Waring, MRPharmS, and others

We would like to congratulate Coleman et al (PDF 70K) on their pilot study of a community pharmacy run anticoagulation clinic (PJ, 4 December 2004, pp822–4) and share our experiences at Sheffield South East Primary Care Trust.

We currently have 10 GP practices involved in a near patient anticoagulation testing (NPAT) service. By April 2005 we aim to be managing the anticoagulation for approximately 700 patients in primary care and have 14 accredited anticoagulation practitioners.

A variety of models are being used which reflect the diversity and need for flexibility in the primary care setting. The clinics range from established NPAT clinics to those in their infancy. The anticoagulation practitioners include community pharmacists, a practice-based pharmacist, practice and district nurses and a GP. Several of our clinics have trained health care assistants to use the CoaguChek machine so that housebound patients can also benefit from the more localised service.

Our community pharmacy anticoagulation service currently manages 25 warfarin patients attached to three GP practices and aims to take over the care of another 25 patients soon. The clinic is run on a set morning each week when the pharmacy is staffed by two trained anticoagulation pharmacists. Written dosing information is communicated to the GP as well as the patient.

Close liaison and discussion with secondary care anticoagulation practitioners has been essential for the development of this service. Input from the local consultant haematologist has been crucial for development of standard operating procedures and clinical guidelines, and liaison with secondary care anticoagulation clinics is vital for the safe and appropriate transfer of patients from secondary care into primary care management. Developing links with anticoagulation co-ordinators from neighbouring PCTs has also been useful for sharing experience and workload.

We believe our primary care-based NPAT clinics will benefit patients through greater access and regular interaction with a health care professional and that their anticoagulation management should improve through greater understanding, as well as having the advantage of being a more localised service. Patient feedback so far has been positive but plans for early 2005 include a patient satisfaction survey as part of the service evaluation.

Future work will include feasibility testing for the expansion of the NPAT services through the PCT. Financial constraints may mean that for smaller GP practices a more viable option would be to provide a central but local service and a community pharmacy may be ideally placed to provide this service. With the new pharmacy contract and supplementary prescribing, remuneration and support for this process is in place and the potential for pharmacists to expand their role is there for the taking again.

Brigitte Waring
Clinical Practice and Anticoagulation Lead Pharmacist
Sheffield SE PCT

Tina Cooke
Vantage Pharmacy
Sheffield

Steve Morris
Director of Primary Care and Chief Pharmacist
Sheffield SE PCT

Send your letter to The Editor

Previous Topic (Morphine sulphate)
Next Topic (Slimming clubs)

Back to Top


©The Pharmaceutical Journal